Identification of the Heme Adduct and an Active Site Peptide Modified during Mechanism-Based Inactivation of Rat Liver Cytochrome P450 2B1 by Secobarbital-Reference-Cited by-同舟云学术

Identification of the Heme Adduct and an Active Site Peptide Modified during Mechanism-Based Inactivation of Rat Liver Cytochrome P450 2B1 by Secobarbital

Published:1996-01-01 Issue:3 Volume:9 Page:614-622
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

He Kan¹,Falick Arnold M.¹,Chen Baili¹,Nilsson Fredrik¹,Correia Maria Almira¹

Affiliation:

1. Departments of Cellular and Molecular Pharmacology, Pharmacy, and Pharmaceutical Chemistry and the Liver Center, University of California, San Francisco, California 94143

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx950177k

Reference34 articles.

1. Structural Basis of Selective Cytochrome P450 Inhibition

2. Cytochrome P450

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theoretical Study of Hydroxylation of α- and β-Pinene by a Cytochrome P450 Monooxygenase Model;International Journal of Molecular Sciences;2023-03-08

2. High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation;Methods in Enzymology;2023

3. Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions;Pharmacology & Therapeutics;2020-02

4. Contribution of Metabolites to P450 Inhibition–Based Drug–Drug Interactions: Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group;Drug Metabolism and Disposition;2015-02-05

5. Inhibition of Cytochrome P450 Enzymes;Cytochrome P450;2015